SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-012927
Filing Date
2022-08-09
Accepted
2022-08-09 17:09:52
Documents
16
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20220809x8k.htm   iXBRL 8-K 39950
2 EX-99.1 olma-20220809xex99d1.htm EX-99.1 145232
3 EX-99.2 olma-20220809xex99d2.htm EX-99.2 12062
4 GRAPHIC olma-20220809xex99d1002.jpg GRAPHIC 6659
5 GRAPHIC olma-20220809xex99d2002.jpg GRAPHIC 6659
  Complete submission text file 0001558370-22-012927.txt   353878

Data Files

Seq Description Document Type Size
6 EX-101.SCH olma-20220809.xsd EX-101.SCH 3035
7 EX-101.LAB olma-20220809_lab.xml EX-101.LAB 15931
8 EX-101.PRE olma-20220809_pre.xml EX-101.PRE 10056
10 EXTRACTED XBRL INSTANCE DOCUMENT olma-20220809x8k_htm.xml XML 4819
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 221149357
SIC: 2834 Pharmaceutical Preparations